BIO-TECHNE Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
BIO-TECHNE Corp (TECH) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $40.70 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-24
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $7.90M, a 558.33% increase year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $12.60M, a 70.27% increase year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $1.40M, a 70.83% decline year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $18.80M, a 20.00% decline year-over-year.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2026 was $40.70M, a 10.30% increase from fiscal 2025.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $36.90M, a 63.39% decline from fiscal 2024.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $100.80M, a 11.75% increase from fiscal 2023.
- BIO-TECHNE Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $90.20M, a 56.90% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $20.50M derived: sum of 2 quarters · filed 2026-08-24 | $21.90M derived: sum of 3 quarters · filed 2026-08-24 | $40.70M 10-K · filed 2026-08-24 | ||
| 2026-03-31 | $12.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $14.00M derived: sum of 2 quarters · filed 2026-05-06 | $32.80M 10-Q · filed 2026-05-06 | $34.00M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2025-12-31 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $20.20M 10-Q · filed 2026-02-04 | $21.40M derived: sum of 3 quarters · filed 2026-08-24 | $28.80M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2025-09-30 | $18.80M 10-Q · filed 2025-11-05 | $20.00M derived: sum of 2 quarters · filed 2026-08-24 | $27.40M derived: sum of 3 quarters · filed 2026-08-24 | $32.20M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2025-06-30 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $8.60M derived: sum of 2 quarters · filed 2026-08-24 | $13.40M derived: sum of 3 quarters · filed 2026-08-24 | $36.90M 10-K · filed 2026-08-24 | ||
| 2025-03-31 | $7.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $12.20M derived: sum of 2 quarters · filed 2026-05-06 | $35.70M 10-Q · filed 2026-05-06 | $63.40M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2024-12-31 | $4.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $28.30M 10-Q · filed 2026-02-04 | $56.00M derived: sum of 3 quarters · filed 2026-08-24 | $67.50M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2024-09-30 | $23.50M 10-Q · filed 2025-11-05 | $51.20M derived: sum of 2 quarters · filed 2026-08-24 | $62.70M derived: sum of 3 quarters · filed 2026-08-24 | $70.00M derived: sum of 4 quarters · filed 2026-08-24 | ||
| 2024-06-30 | $27.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $39.20M derived: sum of 2 quarters · filed 2026-08-24 | $46.50M derived: sum of 3 quarters · filed 2026-08-24 | $100.80M 10-K · filed 2026-08-24 | ||
| 2024-03-31 | $11.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $18.80M derived: sum of 2 quarters · filed 2025-05-08 | $73.10M 10-Q · filed 2025-05-08 | $89.20M derived: sum of 4 quarters · filed 2025-08-22 | ||
| 2023-12-31 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | $61.60M 10-Q · filed 2025-02-06 | $77.70M derived: sum of 3 quarters · filed 2025-08-22 | $103.30M derived: sum of 4 quarters · filed 2025-08-22 | ||
| 2023-09-30 | $54.30M 10-Q · filed 2024-11-05 | $70.40M derived: sum of 2 quarters · filed 2025-08-22 | $96.00M derived: sum of 3 quarters · filed 2025-08-22 | $103.40M derived: sum of 4 quarters · filed 2025-08-22 | ||
| 2023-06-30 | $16.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $41.70M derived: sum of 2 quarters · filed 2025-08-22 | $49.10M derived: sum of 3 quarters · filed 2025-08-22 | $90.20M 10-K · filed 2025-08-22 | ||
| 2023-03-31 | $25.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $33.00M derived: sum of 2 quarters · filed 2024-05-06 | $74.10M 10-Q · filed 2024-05-06 | $87.10M derived: sum of 4 quarters · filed 2024-08-22 | ||
| 2022-12-31 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $48.50M 10-Q · filed 2024-02-07 | $61.50M derived: sum of 3 quarters · filed 2024-08-22 | $87.10M derived: sum of 4 quarters · filed 2024-08-22 | ||
| 2022-09-30 | $41.10M 10-Q · filed 2023-11-07 | $54.10M derived: sum of 2 quarters · filed 2024-08-22 | $79.70M derived: sum of 3 quarters · filed 2024-08-22 | $127.60M derived: sum of 4 quarters · filed 2024-08-22 | ||
| 2022-06-30 | $13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $38.60M derived: sum of 2 quarters · filed 2024-08-22 | $86.50M derived: sum of 3 quarters · filed 2024-08-22 | $209.30M 10-K · filed 2024-08-22 | ||
| 2022-03-31 | $25.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $73.50M derived: sum of 2 quarters · filed 2023-05-08 | $196.30M 10-Q · filed 2023-05-08 | $233.90M derived: sum of 4 quarters · filed 2023-08-23 | ||
| 2021-12-31 | $47.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | $170.70M 10-Q · filed 2023-02-07 | $208.30M derived: sum of 3 quarters · filed 2023-08-23 | $265.70M derived: sum of 4 quarters · filed 2023-08-23 | ||
| 2021-09-30 | $122.80M 10-Q · filed 2022-11-07 | $160.40M derived: sum of 2 quarters · filed 2023-08-23 | $217.80M derived: sum of 3 quarters · filed 2023-08-23 | $251.50M derived: sum of 4 quarters · filed 2023-08-23 | ||
| 2021-06-30 | $37.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $95.00M derived: sum of 2 quarters · filed 2023-08-23 | $128.70M derived: sum of 3 quarters · filed 2023-08-23 | $145.60M 10-K · filed 2023-08-23 | ||
| 2021-03-31 | $57.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $91.10M derived: sum of 2 quarters · filed 2022-05-09 | $108.00M 10-Q · filed 2022-05-09 | $158.70M derived: sum of 4 quarters · filed 2022-08-24 | ||
| 2020-12-31 | $33.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $50.60M 10-Q · filed 2022-02-07 | $101.30M derived: sum of 3 quarters · filed 2022-08-24 | $114.60M derived: sum of 4 quarters · filed 2022-08-24 | ||
| 2020-09-30 | $16.90M 10-Q · filed 2021-11-08 | $67.60M derived: sum of 2 quarters · filed 2022-08-24 | $80.90M derived: sum of 3 quarters · filed 2022-08-24 | $104.60M derived: sum of 4 quarters · filed 2022-08-24 | ||
| 2020-06-30 | $50.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $64.00M derived: sum of 2 quarters · filed 2022-08-24 | $87.70M derived: sum of 3 quarters · filed 2022-08-24 | $99.30M 10-K · filed 2022-08-24 | ||
| 2020-03-31 | $13.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $37.00M derived: sum of 2 quarters · filed 2021-05-07 | $48.60M 10-Q · filed 2021-05-07 | $185.30M derived: sum of 4 quarters · filed 2021-08-25 | ||
| 2019-12-31 | $23.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $35.30M 10-Q · filed 2021-02-08 | $172.00M derived: sum of 3 quarters · filed 2021-08-25 | $178.00M derived: sum of 4 quarters · filed 2021-08-25 | ||
| 2019-09-30 | $11.60M 10-Q · filed 2020-11-09 | $148.30M derived: sum of 2 quarters · filed 2021-08-25 | $154.30M derived: sum of 3 quarters · filed 2021-08-25 | $155.70M derived: sum of 4 quarters · filed 2021-08-25 | ||
| 2019-06-30 | $136.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $142.70M derived: sum of 2 quarters · filed 2021-08-25 | $144.10M derived: sum of 3 quarters · filed 2021-08-25 | $159.00M 10-K · filed 2021-08-25 | ||
| 2019-03-31 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | $7.40M derived: sum of 2 quarters · filed 2020-05-11 | $22.30M 10-Q · filed 2020-05-11 | $26.60M derived: sum of 4 quarters · filed 2020-08-26 | ||
| 2018-12-31 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $16.30M 10-Q · filed 2020-02-06 | $20.60M derived: sum of 3 quarters · filed 2020-08-26 | $24.10M derived: sum of 4 quarters · filed 2020-08-26 | ||
| 2018-09-30 | $14.90M 10-Q · filed 2019-11-06 | $19.20M derived: sum of 2 quarters · filed 2020-08-26 | $22.70M derived: sum of 3 quarters · filed 2020-08-26 | $24.60M derived: sum of 4 quarters · filed 2020-08-26 | ||
| 2018-06-30 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $7.80M derived: sum of 2 quarters · filed 2020-08-26 | $9.70M derived: sum of 3 quarters · filed 2020-08-26 | $10.60M 10-K · filed 2020-08-26 | ||
| 2018-03-31 | $3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | $5.40M derived: sum of 2 quarters · filed 2019-05-07 | $6.30M 10-Q · filed 2019-05-07 | $7.20M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2017-12-31 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | $2.80M 10-Q · filed 2019-02-07 | $3.70M derived: sum of 3 quarters · filed 2019-11-06 | $4.10M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2017-09-30 | $900.00K 10-Q · filed 2018-11-07 | $1.80M derived: sum of 2 quarters · filed 2019-11-06 | $2.20M derived: sum of 3 quarters · filed 2019-11-06 | $2.30M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2017-06-30 | $900.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $1.30M derived: sum of 2 quarters · filed 2019-11-06 | $1.40M derived: sum of 3 quarters · filed 2019-11-06 | $2.30M 10-K/A · filed 2019-11-06 | ||
| 2017-03-31 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $500.00K derived: sum of 2 quarters · filed 2018-05-09 | $1.40M 10-Q · filed 2018-05-09 | $3.20M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-12-31 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | $1.00M 10-Q · filed 2018-02-08 | $2.80M derived: sum of 3 quarters · filed 2018-08-27 | $2.90M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-09-30 | $900.00K 10-Q · filed 2017-11-09 | $2.70M derived: sum of 2 quarters · filed 2018-08-27 | $2.80M derived: sum of 3 quarters · filed 2018-08-27 | $2.80M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $1.90M derived: sum of 2 quarters · filed 2018-08-27 | $1.90M derived: sum of 3 quarters · filed 2018-08-27 | $2.40M 10-K · filed 2018-08-27 | ||
| 2016-03-31 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $100.00K derived: sum of 2 quarters · filed 2017-05-10 | $600.00K 10-Q · filed 2017-05-10 | $700.00K derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $500.00K 10-Q · filed 2017-02-09 | $600.00K derived: sum of 3 quarters · filed 2017-09-07 | $1.80M derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-09-30 | $500.00K 10-Q · filed 2016-11-09 | $600.00K derived: sum of 2 quarters · filed 2017-09-07 | $1.80M derived: sum of 3 quarters · filed 2017-09-07 | $3.80M derived: sum of 4 quarters · filed 2017-09-07 | ||
| 2015-06-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $1.30M derived: sum of 2 quarters · filed 2017-09-07 | $3.30M derived: sum of 3 quarters · filed 2017-09-07 | $3.50M 10-K · filed 2017-09-07 | ||
| 2015-03-31 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $3.20M derived: sum of 2 quarters · filed 2016-05-10 | $3.40M 10-Q · filed 2016-05-10 | $5.10M derived: sum of 4 quarters · filed 2016-08-29 | ||
| 2014-12-31 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | $2.20M 10-Q · filed 2016-02-09 | $3.90M derived: sum of 3 quarters · filed 2016-08-29 | $4.60M derived: sum of 4 quarters · filed 2016-08-29 | ||
| 2014-09-30 | $200.00K 10-Q · filed 2015-11-09 | $800.00K 10-Q · filed 2014-11-10 | $1.90M derived: sum of 2 quarters · filed 2016-08-29 | $2.60M derived: sum of 3 quarters · filed 2016-08-29 | $3.70M derived: sum of 4 quarters · filed 2016-08-29 | |
| 2014-06-30 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $2.40M derived: sum of 2 quarters · filed 2016-08-29 | $3.50M derived: sum of 3 quarters · filed 2016-08-29 | $3.70M 10-K · filed 2016-08-29 | ||
| 2014-03-31 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $1.80M derived: sum of 2 quarters · filed 2015-05-11 | $2.00M 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | $1.30M 10-Q · filed 2015-02-09 | ||||
| 2013-09-30 | $200.00K 10-Q · filed 2014-11-10 | |||||
| 2013-06-30 | $400.00K 10-K · filed 2015-08-31 | $405.00K 10-K · filed 2013-08-29 | ||||
| 2012-09-30 | $40.00K 10-Q · filed 2012-11-09 | $70.00K derived: sum of 2 quarters · filed 2014-08-29 | $306.00K derived: sum of 3 quarters · filed 2014-08-29 | $306.00K derived: sum of 4 quarters · filed 2014-08-29 | ||
| 2012-06-30 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $266.00K derived: sum of 2 quarters · filed 2014-08-29 | $266.00K derived: sum of 3 quarters · filed 2014-08-29 | $300.00K 10-K · filed 2014-08-29 | $338.00K 10-K · filed 2012-08-29 | |
| 2012-03-31 | $236.00K 10-Q · filed 2012-05-10 | $236.00K derived: sum of 2 quarters · filed 2012-05-10 | $270.00K 10-Q · filed 2012-05-10 | $1.57M derived: sum of 4 quarters · filed 2013-08-29 | ||
| 2011-12-31 | $0.00 10-Q · filed 2012-02-07 | $34.00K 10-Q · filed 2012-02-07 | $1.33M derived: sum of 3 quarters · filed 2013-08-29 | $1.33M derived: sum of 4 quarters · filed 2013-08-29 | ||
| 2011-09-30 | $34.00K 10-Q · filed 2012-11-09 | $1.33M derived: sum of 2 quarters · filed 2013-08-29 | $1.33M derived: sum of 3 quarters · filed 2013-08-29 | $2.83M derived: sum of 4 quarters · filed 2013-08-29 | ||
| 2011-06-30 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $1.30M derived: sum of 2 quarters · filed 2013-08-29 | $2.80M derived: sum of 3 quarters · filed 2013-08-29 | $3.10M 10-K · filed 2013-08-29 | ||
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | $1.50M derived: sum of 2 quarters · filed 2012-05-10 | $1.80M 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | $1.50M 10-Q · filed 2012-02-07 | $1.80M 10-Q · filed 2012-02-07 | ||||
| 2010-09-30 | $317.00K 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $1.60M 10-K · filed 2012-08-29 | |||||
| 2009-06-30 | $648.00K 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |